Our hypothesis is supported by reports from studies which have shown that FASN knockdown via siRNA can reduce Gli1 levels in gastric cancer cells, suggesting that FASN may contribute to tumorigenesis and metastasis [42]. The gene discussed is GLI1; the disease is gastric cancer.